XERS Stock Price
Xeris Biopharma Holdings, Inc.
XERS stock price is $16.28 (+2.81% on the day), giving Xeris Biopharma Holdings, Inc. a market cap of $2.97B. Below are the price chart, the MarketXLS Rank, the company profile and the latest news.
XERS Stock Overview
- Price
- $16.27
- Previous close
- $15.83
- Open
- $15.99
- Market cap
- $2.97B
- 52-week range
- $5.25 - $15.21
- 1-year price target
- $14.00
- Sector
- Healthcare
- Industry
- Biotechnology
- Exchange
- Nasdaq
- MarketXLS Rank
- 69
About Xeris Biopharma Holdings, Inc.
Xeris Biopharma Holdings, Inc., a commercial-stage biopharmaceutical company, engages in developing and commercializing therapies for chronic endocrine and neurological diseases in Illinois. The company offers Gvoke, a ready-to-use liquid-stable glucagon for the treatment of severe hypoglycemia in pediatric and adult patients; Keveyis, a therapy for the treatment of hyperkalemic, hypokalemic, and related variants of primary periodic paralysis; and Recorlev, a cortisol synthesis inhibitor for the treatment of endogenous hypercortisolemia in adult patients with Cushing's syndrome. It is also developing XP-8121, a once-weekly subcutaneous injection of levothyroxine that is in phase 3 clinical trial for the treatment of hypothyroidism. The company was incorporated in 2005 and is headquartered in Chicago, Illinois.
| A | B | C | D | |
|---|---|---|---|---|
| 1 | Symbol | Price | Change | Vol |
| 2 | XERS | $16.28 | +2.8% | 2.12M |
| 3 | ||||
| 4 | ||||
| 5 | ||||
| 6 |
Get Xeris Biopharma Holdings, Inc. Data in Excel
Stream real-time data directly to your spreadsheets
BUY NOW